Inspire Medical Systems Inc
INSP
Market Cap$7B
Close$
$231.13
4.4% downside
Current Fair Value
4.4% downsideOvervalued by 4.4% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $7.00 Billion |
|---|---|
| Enterprise Value | $6.54 Billion |
| Dividend Yield | $0.0 (0.0%) |
| Earnings per Share | $-0.72 |
| Beta | 0.0 |
| Outstanding Shares | 30,297,311 |
| Avg 30 Day Volume | 551,069 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | -330.87 |
|---|---|
| PEG | -89.75 |
| Price to Sales | 12.08 |
| Price to Book Ratio | 13.43 |
| Enterprise Value to Revenue | 10.47 |
| Enterprise Value to EBIT | -162.37 |
| Enterprise Value to Net Income | -310 |
| Total Debt to Enterprise | 0 |
| Debt to Equity | 0 |
Revenue Sources
No data
ESG Score
No data
About Inspire Medical Systems Inc
CEO: Timothy Herbert Inspire is a medical technology company focused on the development and commercialization of innovative and minimally invasive solutions for patients with obstructive sleep apnea. Inspire's proprietary Inspire therapy is the first and onl...